General Information of This Metabolic Reaction (MR) (ID: MR006045)
Formula
CYP2C9 ...
SVG example
Hydrolyzationn
Reactant EMD-128130 Product Sarizotan metabolite M364A
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 2C9 (CYP2C9) DME Info
DME Info
DME Info
Cytochrome P450 2A6 (CYP2A6) DME Info
Metabolic Type Oxidation - Hydrolyzationn
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR006041 EMD-128130 EMD 329989 Oxidation - Hydrolyzationn EMD-128130 [1]
MR006050 EMD-128130 Sarizotan metabolite M203 Conjugation - Glycosylation EMD-128130 [2]
MR006048 EMD-128130 Sarizotan metabolite M364D Oxidation - Monohydroxylation EMD-128130 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR006046 Sarizotan metabolite M364A Sarizotan metabolite M203 Unclear EMD-128130 [1]
References
1 In vitro characterization of sarizotan metabolism: hepatic clearance, identification and characterization of metabolites, drug-metabolizing enzyme identification, and evaluation of cytochrome p450 inhibition. Drug Metab Dispos. 2010 Jun;38(6):905-16.
2 Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.